Corrupted adipose tissue endogenous myelopoiesis initiates diet-induced metabolic disease

  1. Elodie Luche
  2. Virginie Robert
  3. Vincent Cuminetti
  4. Céline Pomié
  5. Quentin Sastourné-Array
  6. Aurélie Waget
  7. Emmanuelle Arnaud
  8. Audrey Varin
  9. Elodie Labit
  10. Patrick Laharrague
  11. Remy Burcelin
  12. Louis Casteilla
  13. Beatrice Cousin  Is a corresponding author
  1. Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, France
  2. INSERM U1048, France
  3. Université de Toulouse, EFS, INP-ENVT, Inserm U1031, UPS; BP 84225, France
  4. U1048 , France
  5. STROMALab, France

Abstract

Activation and increased numbers of inflammatory macrophages, in adipose tissue (AT) are deleterious in metabolic diseases. Up to now, AT macrophages (ATM) accumulation was considered to be due to blood infiltration or local proliferation, although the presence of resident hematopoietic stem/progenitor cells (Lin-/Sca+/c-Kit+; LSK phenotype) in the AT (AT-LSK) has been reported. By using transplantation of sorted AT-LSK and gain and loss of function studies we show that some of the inflammatory ATM inducing metabolic disease, originate from resident AT-LSK. Transplantation of AT-LSK sorted from high fat diet-fed (HFD) mice is sufficient to induce ATM accumulation, and to transfer metabolic disease in control mice. Conversely, the transplantation of control AT-LSK improves both AT-inflammation and glucose homeostasis in HFD mice. Our results clearly demonstrate that resident AT-LSK are one of the key point of metabolic disease, and could thus constitute a new promising therapeutic target to fight against metabolic disease.

Article and author information

Author details

  1. Elodie Luche

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Virginie Robert

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Vincent Cuminetti

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Céline Pomié

    INSERM U1048, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Quentin Sastourné-Array

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Aurélie Waget

    INSERM U1048, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Emmanuelle Arnaud

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Audrey Varin

    STROMALab, Université de Toulouse, EFS, INP-ENVT, Inserm U1031, UPS; BP 84225, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Elodie Labit

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Patrick Laharrague

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Remy Burcelin

    U1048 , Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Louis Casteilla

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Beatrice Cousin

    Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, STROMALab, Toulouse, France
    For correspondence
    beatrice.cousin@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2952-4601

Funding

Aviesan/AstraZeneca

  • Louis Casteilla
  • Beatrice Cousin

Société Francophone du Diabète

  • Beatrice Cousin

ANR (ANR 16-CE14-0006-01)

  • Beatrice Cousin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Michael Czech, University of Massachusetts Medical School, United States

Ethics

Animal experimentation: Animals were maintained in accordance to guidelines of the European Community Council. All experimental procedures were done in compliance with European regulations for animal experimentation. The authors have received requested approval from their Institutional Ethic Committee, and from Ministry of National Education, Higher Education and Research (# 2691-2015110616015905) for all the experiments performed.

Version history

  1. Received: January 9, 2017
  2. Accepted: June 28, 2017
  3. Accepted Manuscript published: June 28, 2017 (version 1)
  4. Version of Record published: July 13, 2017 (version 2)

Copyright

© 2017, Luche et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,018
    views
  • 206
    downloads
  • 15
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Elodie Luche
  2. Virginie Robert
  3. Vincent Cuminetti
  4. Céline Pomié
  5. Quentin Sastourné-Array
  6. Aurélie Waget
  7. Emmanuelle Arnaud
  8. Audrey Varin
  9. Elodie Labit
  10. Patrick Laharrague
  11. Remy Burcelin
  12. Louis Casteilla
  13. Beatrice Cousin
(2017)
Corrupted adipose tissue endogenous myelopoiesis initiates diet-induced metabolic disease
eLife 6:e23194.
https://doi.org/10.7554/eLife.23194

Share this article

https://doi.org/10.7554/eLife.23194

Further reading

    1. Computational and Systems Biology
    2. Developmental Biology
    Gang Xue, Xiaoyi Zhang ... Zhiyuan Li
    Research Article

    Organisms utilize gene regulatory networks (GRN) to make fate decisions, but the regulatory mechanisms of transcription factors (TF) in GRNs are exceedingly intricate. A longstanding question in this field is how these tangled interactions synergistically contribute to decision-making procedures. To comprehensively understand the role of regulatory logic in cell fate decisions, we constructed a logic-incorporated GRN model and examined its behavior under two distinct driving forces (noise-driven and signal-driven). Under the noise-driven mode, we distilled the relationship among fate bias, regulatory logic, and noise profile. Under the signal-driven mode, we bridged regulatory logic and progression-accuracy trade-off, and uncovered distinctive trajectories of reprogramming influenced by logic motifs. In differentiation, we characterized a special logic-dependent priming stage by the solution landscape. Finally, we applied our findings to decipher three biological instances: hematopoiesis, embryogenesis, and trans-differentiation. Orthogonal to the classical analysis of expression profile, we harnessed noise patterns to construct the GRN corresponding to fate transition. Our work presents a generalizable framework for top-down fate-decision studies and a practical approach to the taxonomy of cell fate decisions.

    1. Developmental Biology
    2. Evolutionary Biology
    Zhuqing Wang, Yue Wang ... Wei Yan
    Research Article

    Despite rapid evolution across eutherian mammals, the X-linked MIR-506 family miRNAs are located in a region flanked by two highly conserved protein-coding genes (SLITRK2 and FMR1) on the X chromosome. Intriguingly, these miRNAs are predominantly expressed in the testis, suggesting a potential role in spermatogenesis and male fertility. Here, we report that the X-linked MIR-506 family miRNAs were derived from the MER91C DNA transposons. Selective inactivation of individual miRNAs or clusters caused no discernible defects, but simultaneous ablation of five clusters containing 19 members of the MIR-506 family led to reduced male fertility in mice. Despite normal sperm counts, motility, and morphology, the KO sperm were less competitive than wild-type sperm when subjected to a polyandrous mating scheme. Transcriptomic and bioinformatic analyses revealed that these X-linked MIR-506 family miRNAs, in addition to targeting a set of conserved genes, have more targets that are critical for spermatogenesis and embryonic development during evolution. Our data suggest that the MIR-506 family miRNAs function to enhance sperm competitiveness and reproductive fitness of the male by finetuning gene expression during spermatogenesis.